婴儿肌纤维素瘤与皮肤,内脏和中枢神经系统的参与:多模式治疗方法
Stephanie Gehle1, Carolyn Quinsey2, Diana McShane3
1Departments of Pediatrics.
Journal of pediatric hematology/oncology
|August 1, 2023
概括
婴儿肌纤维素瘤 (IM) 是一种罕见的瘤. 这一案例突出显示了多中心性IM的成功治疗中枢神经系统 (CNS) 参与使用化疗和内甲索.
科学领域:
- 儿科瘤学 儿科瘤学
- 皮肤病学 皮肤病学
- 神经学 神经学
背景情况:
- 婴儿肌纤维素瘤 (IM) 是婴儿时期的一种罕见良性瘤.
- 虽然单独的和一些多中心的IM病例自发退化,但内脏参与的患者的预后不好.
- 中枢神经系统 (CNS) 在多中心IM中的参与很少被报告,没有记录的生存数据.
研究的目的:
- 报告一个新生儿患有多中心婴儿肌纤维化病的病例,该病例涉及皮肤,内脏和中枢神经系统.
- 描述这种罕见的IM表现的治疗和结果.
主要方法:
- 该患者是一名新生儿,患有多中心性IM,接受了治疗方案.
- 该疗法包括芬布拉斯和甲基酸盐化疗.
- 进行了新增的一种注射甲索特雷克萨的新增药物.
主要成果:
- 患者在治疗一年后表现出治疗反应.
- 多式联络方法在管理复杂的IM方面表现出有效性.
结论:
- 有关中枢神经系统的多中心婴儿肌纤维素瘤可以成功治疗.
- 多种模式的治疗策略,包括化疗和内甲状腺素,是有效的.
- 这种方法为在严重的IM病例中改善结果提供了潜在的途径.
更多相关视频
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
897
08:07Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development
Published on: July 1, 2020
7.8K
相关概念视频
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
